Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034

Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

Registro
Iniciar sesión

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD

Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Artículo de revisión

Sangrado uterino anormal y PALM COEIN

Abnormal uterine bleeding and PALM COEIN.

Ginecol Obstet Mex. 2020 enero;88(1):59-67.

https://doi.org/10.24245/gom.v88i1.3467

Janer Sepúlveda-Agudelo,1 Andrea Juliana Sepúlveda-Sanguino2

1 Ginecoobstetra, Departamento de Ginecoobstetricia, Universidad Industrial de Santander; especialista en Cirugía endoscópica ginecológica; profesor titular, Grupo de Investigación GINO, Bucaramanga, Colombia.
2 Estudiante de Medicina, Universidad Industrial de Santander, Bucaramanga, Colombia.


Corrrespondencia:

Janer Sepúlveda Agudelo
janersepulveda@yahoo.es

Debe citarse como:

Sepúlveda-Agudelo J, Sepúlveda-Sanguino AJ. Sangrado uterino anormal y PALM COEIN. Ginecol Obstet Mex. 2020 enero;88(1):59-67. https://doi.org/10.24245/gom.v88i1.3467

Resumen

OBJETIVO: Comunicar la nueva terminología del sangrado uterino anormal y de la  clasificación PALM COEIN.

MÉTODO: Búsqueda bibliográfica de artículos publicados en inglés o español con la palabra clave PALM COEIN. Desde el primer artículo publicado en 2010 hasta 2018 en las bases de datos MedLine, PubMed, Embase y Ovid.

RESULTADOS: Se reunieron 64 artículos, pero solo 18 mencionaban el término, 24 eran repetidos. Se seleccionaron 22 que trataban el tema en estudio y eran referidos con la clasificación actual, de esos trabajos 6 eran de cohorte, 2 de revisión sistemática, 2 boletines y 12 revisiones de tema.

CONCLUSIÓN: Esta nueva terminología facilitará el entendimiento y la comunicación, independiente del idioma y la cultura, además del acercamiento más entendible con nuestras pacientes. La clasificación PALM COEIN facilita la investigación epidemiológica, etiológica y el tratamiento de las pacientes con sangrado uterino anormal.

PALABRAS CLAVE: Sangrado uterino anormal; PALM COEIN; lenguaje; enfermedades uterinas; hemorragia uterina; estudios de cohorte.

Abstract

OBJECTIVE: To update the new terminology of abnormal uterine bleeding and the PALM COEIN classification

METHOD: Bibliographic search of articles published in English or Spanish with the keyword PALM COEIN. From the first article published in 2010 to 2018 in the MedLine, PubMed, Embase and Ovid databases.

RESULTS: 64 articles were collected, but only 18 mentioned the term, 24 were repeated. 22 were selected that dealt with the subject under study and were referred to with the current classification, of these works 6 were cohort, 2 systematic review, 2 newsletters and 12 theme reviews.

CONCLUSION: This new terminology will facilitate understanding and communication, independent of language and culture, in addition to the most understandable approach with our patients. This classification of PALM COEIN facilitates the epidemiological, etiological investigation and treatment of patients with abnormal uterine bleeding.

KEYWORDS: Abnormal uterine bleeding; Language; Uterine diseases; Uterine hemorrhage; Cohort Studies.

    1. Bandi ND, et al. Utility of the PALM-COEIN classification of abnormal uterine bleeding for Indian gynecologists. Int J Gynecol Obstet. 2016; 133: 196-98. doi: 10.1016/j.ijgo.2015.09.030
    2. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65. doi: 10.1016/j.bpobgyn.2015.11.012
    3. Bahamondes L, Ali M. Recent advances in managing and understanding menstrual disorders. Prime Rep. 2015; 7: 33. doi: 10.12703/P7-33
    4. Singh S, et al. Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can 2018; 40 (5): e391-e415. doi: 10.1016/j.jogc.2018.03.007
    5. Sepúlveda J, Díaz G. Detención de la hemorragia uterina anormal en pacientes a quienes se realizó histeroscopia operatoria. Ginecol Obstet Mex. 2018; 86 (1): 13-25. doi: 10.24245/gom.v86i1.1666
    6. Fraser IS, et al. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertility and Sterility. 2007; 87 (3): 466-76. doi: 10.1016/j.fertnstert.2007.01.023
    7. Fraser IS, et al. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Human Reproduction 2007; 22: (3): 635-43. doi: 10.1093/humrep/del478
    8. Woolcock JG, et al. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008; 90: 2269-80. doi: 10.1016/j.fertnstert.2007.10.060
    9. Bacon JL. Abnormal Uterine Bleeding: Current Classification and Clinical Management. Obstet Gynecol Clin North Am. 2017; 44 (2): 179-93. doi: 10.1016/j.ogc.2017.02.012
    10. Munro MG, et al. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am J Obstet Gynecol. 2012; 207 (4): 259-65. doi: 10.1016/j.ajog.2012.01.046
    11. Munro MG. Abnormal uterine bleeding. Cambridge, UK: Cambridge University Press; 2010.
    12. Committee on Practice Bulletins-Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012; 120 (1): 197-206. doi: 10.1097/AOG.0b013e318262e320.
    13. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95: 2204-8. doi: 10.1016/j.fertnstert.2011.03.079
    14. Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 3-22. doi: 10.1016/j.bpobgyn.2016.09.011
    15. American Association of Gynecologic Laparoscopists. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Endometrial Polyps. J Minim Invasive Gynecol. 2012; 19 (1): 3-10. doi: 10.1016/j.jmig.2011.09.003
    16. Vigueras A. Escalona JR. Pólipos endometriales: Actualización en diagnóstico y tratamiento. Rev Chil Obstet Ginecol 2016; 81 (2): 152-8.
    17. Clark TJ, Stevenson H. Endometrial polyps and abnormal uterine bleeding (AUB-P): What is the relationship, how are they diagnosed and how are they treated? Best Pract Res Obstet Gynaecol. 2017; 40: 89-104. doi: 10.1016/j.bpobgyn.2016.09.005
    18. Salim S, et al. Diagnosis and Management of Endometrial Polyps: A Critical Review of the Literature. J Minim Invasive Gynecol 2011; 18: 569-81. doi: 10.1016/j.jmig.2011.05.018.
    19. Beal HN, et al. Endometrial cells identified in cervical cytology in women > or 5 40 years of age: criteria for appropriate endometrial evaluation. Am J Obstet Gynecol 2007; 196: 568. e1-5. doi: 10.1016/j.ajog.2007.01.040
    20. Finco A, et al. Surgical management of abnormal uterine bleeding in fertile age women. Women’s Health (Lond). 2015; 11 (4): 513-25. doi: 10.2217/whe.15.12
    21. Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand. 2010; 89: 992-1002. doi: 10.3109/00016349.2010.493196
    22. Deneris A. PALM-COEIN Nomenclature for Abnormal Uterine Bleeding. J Midwifery Womens Health. 2016; 61 (3): 376-9. doi: 10.1111/jmwh.12440
    23. Munro MG, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113: 3-13. doi: 10.1016/j.ijgo.2010.11.011
    24. Hapangama DK, Bulmer JN. Pathophysiology of heavy menstrual bleeding. Women’s Health 2016; 12 (1): 3-13. doi: 10.2217/whe.15.81
    25. Donnez J, et al. Introduction: Uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018; 109 (3): 369-70. doi: 10.1016/j.fertnstert.2018.01.035.
    26. García-Solares J, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril 2018; 109: 371-9. doi.org/10.1016/j.fertnstert.2017.12.030
    27. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol 2017; 40: 68-81. doi: 10.1016/j.bpobgyn.2016.09.006
    28. Gordts S, et al. Symptoms and classification of uterine adenomyosis. Fertil Steril 2018; 109: 380-8. doi.org/10.1016/j.fertnstert.2018.01.006
    29. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril 2018; 109: 389-97. doi.org/10.1016/j.fertnstert.2018.01.024
    30. Champaneria R, et al. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand 2010; 89: 1374-84. doi: 10.3109/00016349.2010.512061
    31. Lasmar RB, Lasmar BP. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB). Best Pract Res Clin Obstet Gynaecol. 2017; 40: 82-88. doi: 10.1016/j.bpobgyn.2016.09.008
    32. Islam MS, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab. 2013; 98 (3): 921-34. doi: 10.1210/jc.2012-3237
    33. Stewart EA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017; 124 (10): 1501-12. doi: 10.1111/1471-0528.14640
    34. Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Practice & Research Clinical Obstetrics and Gynaecology 2016; 34: 3-12. doi: 10.1016/j.bpobgyn.2015.11.018
    35. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65. doi: 10.1016/j.bpobgyn.2015.11.012.
    36. Sepúlveda J, Alarcón MA. Manejo médico de la miomatosis uterina. Revisión de la literatura. Rev Chil Obstet Ginecol 2016; 81 (1): 48-55. doi: 10.4067/S0717-75262016000100009
    37. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008; 112 (2 Pt 1): 387-400. doi: 10.1097/AOG.0b013e318183fbab
    38. Reis FM, et al. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 13-24. doi: 10.1016/j.bpobgyn.2015.11.015
    39. Islam MS, et al. Growth factors and pathogenesis. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 25-36. doi: 10.1016/j.bpobgyn.2015.08.018
    40. Van Voorhis BJ, et al. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 2002; 47: 663-9.
    41. Dueholm M, Hjorth IM. Structured imaging technique in the gynecologic office for the diagnosis of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 23-43. doi: 10.1016/j.bpobgyn.2016.09.010
    42. Van den Bosch T, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015; 46 (3): 284-98. doi: 10.1002/uog.14806
    43. Parkash V, et al. Committee Opinion No. 631: Endometrial Intraepithelial Neoplasia. Obstet Gynecol 2015; 126 (4): 897. doi: 10.1097/AOG.0000000000001071
    44. Emons G, et al. New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015; 75 (2): 135-6. doi. 10.1055/s-0034-1396256
    45. Adams T, Denny L. Abnormal vaginal bleeding in women with gynaecological malignancies. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 134-47. doi: 10.1016/j.bpobgyn.2016.09.014
    46. Van Hanegem N, et al. The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016; 197: 147-55. doi: 10.1016/j.ejogrb.2015.12.008
    47. ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women with Postmenopausal Bleeding. Obstet Gynecol. 2018; 131(5): e124-e129. doi: 10.1097/AOG.0000000000002631.
    48. Practice bulletin no. 128: Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged Women. Obstet Gynecol.2012; 120: 197-206. doi: 10.1097/AOG.0b013e318262e320.
    49. Committee on Adolescent Health Care; Committee on Gynecologic Practice. Committee Opinion No.580: Von Willebrand Disease in Women. Obstet Gynecol. 2013; 122: 1368-73. doi: 10.1097/01.AOG.0000438961.38979.19.
    50. Kouides PA, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005; 84: 1345-51. doi: 10.1016/j.fertnstert.2005.05.035
    51. Shankar M, et al. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004; 111: 734-40. doi: 10.1111/j.1471-0528.2004.00176.x
    52. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009 Jul;201(1):12.e1-8. doi: 10.1016/j.ajog.2009.04.024
    53. Committee on Practice Bulletins—Gynecology. Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction. Obstet Gynecol. 2013 Jul;122(1):176-85. doi: 10.1097/01. doi: 10.1097/01.AOG.0000431815.52679.bb
    54. Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynecology and Obstetrics 2011; 113:3-13. doi: 10.1016/j.ijgo.2010.11.011
    55. Spremović-Rađenović S, Stefanović A, Kadija S, Jeremić K, Sparić R. Classification and the diagnostics of abnormal uterine bleeding in nongravid women of reproductive age: The PALM-COEIN classification system adopted by the International Federation of Gynecology and Obstetrics. Vojnosanit Pregl. 2016;73(12):1154-9. doi: 10.2298/VSP160709289S
    56. Madhra M, Fraser IS, Munro MG, Critchley HO. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstet Gynecol Scand. 2014;93(7):619-25. doi: 10.1111/aogs.12390
    57. Töz E, Sancı M, Özcan A, Beyan E, İnan AH. Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding. Int J Gynaecol Obstet. 2016;133(3):325-8. doi: 10.1016/j.ijgo.2015.09.033
    58. Mishra D, Sultan S. FIGO’s PALM–COEIN Classification of Abnormal Uterine Bleeding: A Clinico-histopathological Correlation in Indian Setting The Journal of Obstetrics and Gynecology of India 2017;67(2):119–125. doi: 10.1007/s13224-016-0925-8

Comentarios